Market Overview:
The global mycobacterium tuberculosis testing market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The market growth is attributed to the increasing incidence of tuberculosis, growing awareness about early diagnosis and treatment of tuberculosis, and technological advancements in the field of mycobacterium tuberculosis testing. However, the high cost associated with advanced diagnostic tests is expected to restrain the growth of this market during the forecast period. The global mycobacterium tuberculosis testing market can be segmented on the basis of type, application, and region. On the basis of type, it can be divided into point-of-care tests (POC), nuclear acid amplification tests (NAATs), tuberculin skin test (TST), and others such as interferon gamma release assays (IGRAs) and polymerase chain reaction (PCR). On the basis of application, it can be classified into hospitals, specialty clinics, and diagnostic laboratories. Geographically speaking, it can be segmented into North America,, Latin America,, Europe,, Asia Pacific,,and Middle East & Africa,.
Product Definition:
Mycobacterium tuberculosis (MTB) testing is a laboratory test that uses a sample of sputum, blood, or another body fluid or tissue to determine if an individual has MTB. The test can help diagnose pulmonary tuberculosis (TB) and its severity. It can also help guide treatment decisions for individuals with suspected or confirmed TB infection.
Point of Care Test:
The global point of care (POC) test market size was valued at USD 2.6 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence rate of tuberculosis coupled with rising demand for rapid diagnostic tests are some factors attributing towards its growth in the coming years.
Nuclear Acid Amplification Tests:
NAABT is a molecular test used for the detection of mycobacterium tuberculosis in patients' samples. It involves polymerase chain reaction (PCR) technology and is an extension to the acid-fast bacillus assay. The method provides more sensitive and accurate results as compared to conventional culture methods, which makes it one of the most preferred techniques among researchers as well as clinicians.
Application Insights:
The market is segmented into hospitals, specialty clinics and diagnostic laboratories. Hospitals held the largest share of the global revenue in 2017 owing to factors such as increasing prevalence of tuberculosis and government initiatives to increase hospital admissions for diagnosis purposes. For instance, according to WHO, an estimated 10 million people were infected with TB worldwide in 2016; 5 million died from the disease and 3 million were diagnosed with it. In addition, according to estimates published by WHO in 2015, approximately USD 300 billion was spent on treating TB patients across low-income countries that year. Thus there is a huge demand for mycobacterium tuberculosis testing kits at affordable prices within hospitals which will help controlTBcare services at lower costs while ensuring high quality standards.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure and high awareness levels coupled with relatively higher spending capacities of individuals are some factors responsible for its large share. Moreover, the U.S.
Growth Factors:
- Increasing incidence of tuberculosis (TB) across the globe
- Growing awareness about TB and its diagnosis among people
- Rising demand for rapid and accurate TB diagnosis tests
- Technological advancements in TB testing procedures
- Government initiatives to control spread of tuberculosis
Scope Of The Report
Report Attributes
Report Details
Report Title
Mycobacterium Tuberculosis Testing Market Research Report
By Type
Point of Care Test, Nuclear Acid Amplification Tests, Tuberculosis Skin Test, Others
By Application
Hospitals, Specialty Clinics, Diagnostic Laboratories
By Companies
Thermo Fisher Scientific, Danaher, Mediven, Osang Healthcare, Hologic, Roche, Abbott, Novacyt, DAAN Gene
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
159
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Mycobacterium Tuberculosis Testing Market Report Segments:
The global Mycobacterium Tuberculosis Testing market is segmented on the basis of:
Types
Point of Care Test, Nuclear Acid Amplification Tests, Tuberculosis Skin Test, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialty Clinics, Diagnostic Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Danaher
- Mediven
- Osang Healthcare
- Hologic
- Roche
- Abbott
- Novacyt
- DAAN Gene
Highlights of The Mycobacterium Tuberculosis Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Point of Care Test
- Nuclear Acid Amplification Tests
- Tuberculosis Skin Test
- Others
- By Application:
- Hospitals
- Specialty Clinics
- Diagnostic Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mycobacterium Tuberculosis Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mycobacterium tuberculosis (Mtb) testing is a diagnostic procedure used to determine if someone has the infection. Mtb tests measure the amount of Mtb in a person's blood or other body fluid.
Some of the key players operating in the mycobacterium tuberculosis testing market are Thermo Fisher Scientific, Danaher, Mediven, Osang Healthcare, Hologic, Roche, Abbott, Novacyt, DAAN Gene.
The mycobacterium tuberculosis testing market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Mycobacterium Tuberculosis Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Mycobacterium Tuberculosis Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Mycobacterium Tuberculosis Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Mycobacterium Tuberculosis Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Mycobacterium Tuberculosis Testing Market Size & Forecast, 2018-2028
4.5.1 Mycobacterium Tuberculosis Testing Market Size and Y-o-Y Growth
4.5.2 Mycobacterium Tuberculosis Testing Market Absolute $ Opportunity
Chapter 5 Global Mycobacterium Tuberculosis Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Mycobacterium Tuberculosis Testing Market Size Forecast by Type
5.2.1 Point of Care Test
5.2.2 Nuclear Acid Amplification Tests
5.2.3 Tuberculosis Skin Test
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Mycobacterium Tuberculosis Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Mycobacterium Tuberculosis Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialty Clinics
6.2.3 Diagnostic Laboratories
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Mycobacterium Tuberculosis Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Mycobacterium Tuberculosis Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Mycobacterium Tuberculosis Testing Analysis and Forecast
9.1 Introduction
9.2 North America Mycobacterium Tuberculosis Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Mycobacterium Tuberculosis Testing Market Size Forecast by Type
9.6.1 Point of Care Test
9.6.2 Nuclear Acid Amplification Tests
9.6.3 Tuberculosis Skin Test
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Mycobacterium Tuberculosis Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialty Clinics
9.10.3 Diagnostic Laboratories
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Mycobacterium Tuberculosis Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Mycobacterium Tuberculosis Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Mycobacterium Tuberculosis Testing Market Size Forecast by Type
10.6.1 Point of Care Test
10.6.2 Nuclear Acid Amplification Tests
10.6.3 Tuberculosis Skin Test
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Mycobacterium Tuberculosis Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialty Clinics
10.10.3 Diagnostic Laboratories
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Mycobacterium Tuberculosis Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Mycobacterium Tuberculosis Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Mycobacterium Tuberculosis Testing Market Size Forecast by Type
11.6.1 Point of Care Test
11.6.2 Nuclear Acid Amplification Tests
11.6.3 Tuberculosis Skin Test
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Mycobacterium Tuberculosis Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialty Clinics
11.10.3 Diagnostic Laboratories
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Mycobacterium Tuberculosis Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Mycobacterium Tuberculosis Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Mycobacterium Tuberculosis Testing Market Size Forecast by Type
12.6.1 Point of Care Test
12.6.2 Nuclear Acid Amplification Tests
12.6.3 Tuberculosis Skin Test
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Mycobacterium Tuberculosis Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialty Clinics
12.10.3 Diagnostic Laboratories
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Mycobacterium Tuberculosis Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Mycobacterium Tuberculosis Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Mycobacterium Tuberculosis Testing Market Size Forecast by Type
13.6.1 Point of Care Test
13.6.2 Nuclear Acid Amplification Tests
13.6.3 Tuberculosis Skin Test
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Mycobacterium Tuberculosis Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialty Clinics
13.10.3 Diagnostic Laboratories
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Mycobacterium Tuberculosis Testing Market: Competitive Dashboard
14.2 Global Mycobacterium Tuberculosis Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 Danaher
14.3.3 Mediven
14.3.4 Osang Healthcare
14.3.5 Hologic
14.3.6 Roche
14.3.7 Abbott
14.3.8 Novacyt
14.3.9 DAAN Gene
